Article Information
PubMed
Published By
History
- Received June 28, 2010
- Revision received August 18, 2010
- Accepted August 27, 2010
- First published October 27, 2010.
- Version of record published October 27, 2010.
Copyright & Usage
Copyright © 2010 the authors 0270-6474/10/3014346-10$15.00/0
Author Information
- Paul C. Fletcher1,
- Antonella Napolitano2,
- Andrew Skeggs2,
- Sam R. Miller2,
- Bruno Delafont2,
- Victoria C. Cambridge1,
- Sanne de Wit3,
- Pradeep J. Nathan1,2,
- Allison Brooke2,
- Stephen O'Rahilly4,
- I. Sadaf Farooqi4, and
- Edward T. Bullmore1,2
- 1Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom,
- 2GlaxoSmithKline Clinical Unit Cambridge, Addenbrooke's Centre for Clinical Investigations, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom,
- 3Amsterdam Center for the Study of Adaptive Control in Brain and Behavior, Department of Developmental Psychology, University of Amsterdam, 1018 WB Amsterdam, The Netherlands, and
- 4University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom
- Correspondence should be addressed to either of the following: I. Sadaf Farooqi, University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK, isf20{at}cam.ac.uk; or Paul C. Fletcher, Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Cambridge CB2 0SZ, UK, E-mail: pcf22{at}cam.ac.uk
Author contributions
Disclosures
- Received June 28, 2010.
- Revision received August 18, 2010.
- Accepted August 27, 2010.
-
The study was sponsored by GlaxoSmithKline. P.C.F. was supported by the Wellcome Trust and by the Bernard Wolfe Health Neuroscience Fund. S.O.R. and I.S.F. were supported by the Wellcome Trust, Medical Research Council (MRC) Centre for Obesity and Related Disorders, and National Institute for Health Research Cambridge Biomedical Research Centre. The work was also carried out in the MRC- and Wellcome Trust-funded Behavioural and Clinical Neurosciences Institute.
- Correspondence should be addressed to either of the following: I. Sadaf Farooqi, University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK, isf20{at}cam.ac.uk; or Paul C. Fletcher, Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Cambridge CB2 0SZ, UK, E-mail: pcf22{at}cam.ac.uk